Company expects controlled-release gliclazide tablets to generate $15 million in annual revenues BEIJING, Oct. 19 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ...
Lotus Pharmaceuticals, a Chinese drug developer, announced that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the ...
This leaflet answers some common questions about GLICLAZIDE MR VIATRIS. It does not contain all the available information Reading this leaflet does not take the place of talking to your doctor, ...
Tianyin Pharmaceutical Co., Inc. (TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback